Petco Q1 comps +0.7%, adj. EBITDA $97.3M; reaffirms FY 2026 outlook

Petco Health & Wellness Company, Inc.

Net sales of $1.5B, +0.2% YoY; comparable sales +0.7%, marking return to positive comps.
Gross margin improved 21bps to 38.4%; operating income rose 50.5% to $24.6M.
Adj. EBITDA $97.3M vs $89.4M; net loss widened to $15.1M from $11.7M.
Total debt reduced to $1.482B from $1.593B; cash balance $166.8M.
FY 2026 outlook reaffirmed: net sales flat to +1.5%, adj. EBITDA $415M-$430M; Q2 adj. EBITDA guided $110M-$112M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Petco Health & Wellness Company, Inc. updated its fiscal year 2026 guidance (reaffirmed).

Period: fiscal year 2026
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

The company reaffirmed its full year 2026 net sales and EBITDA outlook and provided its outlook for the second quarter of 2026.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Petco Health & Wellness Company, Inc. reported the quarter ended May 2, 2026 results: revenue $1.5 billion, net income Net loss of $15.1 million.

Period: the quarter ended May 2, 2026
Revenue: $1.5 billion
Net income: Net loss of $15.1 million
Result: reported results

Exact text from the filing

Net sales of $1.5 billion increased 0.2%; comparable sales increased 0.7%.

View on SEC.gov

309 earnings releases filed in the last 30 days. Browse all earnings releases →

Petco Health & Wellness Company, Inc. filing history →

Source: SEC EDGAR

accession 0001826470-26-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.